Emerging Cancer Molecular Diagnostic Tests
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing molecular diagnostic technologies and products for cancer testing.
Contains 45 pages and 1 table
Contains 45 pages and 1 table
1. OVERVIEW
2. MAJOR CANCER TYPES
3. ONCOGENES
2. MAJOR CANCER TYPES
- Prostate
- Lung
- Colon and Rectum
- Breast
- Skin
- Uterine
- Leukemia
- Oral
3. ONCOGENES
- Abl/abl-bcr
- AIB1
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PTI-1
- Ras
- Reg
- Sis
- Src
More Publications
Infectious Disease Molecular Diagnostic Testing
US$ 2,000.00
February 2010
360 pages
The 2012 Global Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country
US$ 1,480.00
March 2012
15 pages
Molecular Diagnostics Market Report: 2011 Edition
US$ 800.00
June 2011
43 pages
The 2012 Spanish Molecular Diagnostics Market
US$ 4,720.00
March 2012
850 pages
The 2012 UK Molecular Diagnostics Market
US$ 4,720.00
March 2012
855 pages
